Endotronix Receives IDE Approval for the Market Expanding PROACTIVE-HF 2 Clinical Trial
(Adnkronos) – NAPERVILLE, Ill., Oct. 9, 2023 /PRNewswire/ — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment of heart failure (HF), announced it has received Investigational
